138 results on '"Hense, Jörg"'
Search Results
2. Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting
3. Time interval between the diagnosis of breast cancer and brain metastases impacts prognosis after metastasis surgery
4. Applicability of a digital health application for cancer patients: a qualitative non-participation analysis.
5. Radiographic markers of breast cancer brain metastases: relation to clinical characteristics and postoperative outcome
6. Relevance of Patient-Reported Outcome Measures in Patients with Cancer: Detection of Underrated Psychological Distress of Palliative Care Patients in an Outpatient Setting
7. HER2 Receptor Conversion Is a strong Survival Predictor in Patients with Breast Cancer Brain Metastases
8. A vaccine targeting mutant IDH1 in newly diagnosed glioma
9. Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy in EGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance.
10. Comparison of Palliative Knowledge and Self-Efficacy Expectation of German Paramedics Between a Rural and an Urban Structured Emergency Medical Service Area
11. Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer center
12. MET Expression in Advanced Non–Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy
13. High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer
14. SOP – Schmerztherapie bei Palliativpatienten
15. Predictors of outpatients’ request for palliative care service at a medical oncology clinic of a German comprehensive cancer center
16. Patient-Reported-Outcome-Messung (PROM) psychosozialer Belastung und Symptome für ambulante Patienten unter kurativer oder palliativer Tumortherapie: Eine retrospektive Analyse eines Comprehensive Cancer Center
17. Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on Prognosis
18. SOP – Schmerztherapie bei Palliativpatienten
19. Grundlagen der Palliativmedizin
20. The OUTREACH study : oncologists of German university hospitals in rotation on a palliative care unit—evaluation of attitude and competence in palliative care and hospice
21. Prediction of Short and Long Survival after Surgery for Breast Cancer Brain Metastases
22. Electrolyte and renal disorders in patients with newly diagnosed glioblastoma
23. Radiographic markers of breast cancer brain metastases: relation to clinical characteristics and postoperative outcome
24. Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients
25. Systemic inflammatory response parameters as prognostic markers in patients with recurrent or metastatic head and neck cancer treated with immunotherapy
26. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen
27. Efficacy of immunotherapy (IO) and subsequent systemic treatment after failure of IO in patients with recurrent or metastatic head and neck cancer in a real-world setting
28. Fatigue, barriers to physical activity and predictors for motivation to exercise in advanced Cancer patients
29. Palliative knowledge and self-efficacy expectation of residents before and after palliative care unit rotation - A national study project
30. Patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC) show highly favorable outcomes with treatment sequences provided at a comprehensive cancer center
31. Brief S2k guidelines - Merkel cell carcinoma
32. S2k Kurzleitlinie - Merkelzellkarzinom
33. Bilateral histological evaluation of exocrine testicular function in men with obstructive azoospermia: condition of spermatogenesis and andrological implications?
34. Electrolyte and renal disorders in patients with newly diagnosed glioblastoma
35. Integration of palliative care into the comprehensive cancer center of Germany - Consultation hours and fellowship rotations of the specialized palliative care
36. Leitlinie : ICD-10 C71 : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen
37. Barriers and motivation of physical activitiy (PA) in patients with cancer related fatigue (CRF)
38. PriCoTTF : A phase I/II single-arm trial of tumor treating fields prior and concomitant with radiotherapy and temozolomide in newly diagnosed glioblastoma
39. Stellungnahme zur Nutzenbewertung des G-BA von Arzneimitteln für seltene Erkrankungen gemäß § 35a SGB V, veröffentlicht am 2. Januar 2018, Vorgangsnummer 2017-10-01-D-308, IQWiG Bericht Nr. 570
40. A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group evaluating a mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomas
41. Integration von Palliativmedizin in onkologische Spitzenzentren Deutschlands – ambulante Sprechstunden und Rotationsprogramme der spezialisierten Palliativmedizin
42. Treatment Outcome in Patients with Primary or Secondary Transformed Indolent B-Cell Lymphomas
43. Leitlinie - ICD-10 C71 : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen
44. ATIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMAS
45. ACTR-49. PriCoTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
46. Integration von Palliativmedizin in onkologische Spitzenzentren Deutschlands – ambulante Sprechstunden und Rotationsprogramme der spezialisierten Palliativmedizin
47. A mutation-specific peptide vaccine targeting IDH1R132H in patients with newly diagnosed malignant astrocytomas: A first-in-man multicenter phase I clinical trial of the German Neurooncology Working Group (NOA-16).
48. Palliative Care at Comprehensive Cancer Center : A comparative look at integration in Germany
49. SOP—pain therapy in palliative care patients
50. WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.